Neoadjuvant Metformin in Association to Chemoradiotherapy for Locally Advanced Rectal Cancer
Status:
Terminated
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
A phase II, randomized study of placebo versus metformin in association to chemotherapy with
capecitabine and radiation in the neoadjuvant treatment of locally advanced (T3-4N0M0 or
TxN1-2M0) rectal carcinomas.